Article: Biogen joins Amgen, Genentech, Genzyme among top four Biotech companies.

M2 PRESSWIRE-15 February 2005-FNWU: Biogen joins Amgen, Genentech, Genzyme among top four Biotech companies(C)1994-2005 M2 COMMUNICATIONS LTD

RDATE:02142005

City of Industry, CA - Biotech industry news provided by Financial News USA (OTC: FNWU). Biogen IDEC (NASDAQ: BIIB) with a market cap of $22 billion is one of Biotech big four companies whose market caps exceed $10 billion. Its two blockbuster products, Avonex and Rituxan, have pushed its revenue over $2 billion. Biogen IDEC also cooperates with Elan (NYSE: ELN) to launch Tysabri in late 2004. This product is likely to be approved in Europe, and its use could expand beyond MS management - data will ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!